No Detail Found!

Angioimmunoblastic t-cell lymphoma:a case report

Author(s)
Sundus Nasim Dow Medical College, Dow University of Health Sciences, Karachi
Dua Azim Dow Medical College, Dow University of Health Sciences, Karachi
Farheen Malik 1Dow Medical College, Dow University of Health Sciences, Karachi
Faryal Tahir Dow Medical College, Dow University of Health Sciences, Karachi
Zehra Ashraf Jinnah University for Women, Karachi
Abdul Qayyum Department for Oncology, Dr. Ziauddin Hospital, Karachi, Pakistan
Abstract
Angioimmunoblastic T-cell lymphoma (AITL) is a rare, aggressive type of non-Hodgkin's lymphoma (NHL) that is mostly diagnosed in elderly patients. Its non-specific clinical presentation (lymphadenopathy, fever, night sweats, weight loss, generalized rash, and hepatosplenomegaly) often results in a delay in the diagnosis. The diagnosis is mainly established based on a detailed clinical evaluation and biopsy findings, and currently, available treatment options include corticosteroids, immunotherapy, and single- or multi-agent chemotherapy. Here, we report a case of a 61-year-old male who presented with complaints of easy fatigability, dyspnea, and fever along with inguinal lymphadenopathy and was diagnosed as a case of AITL. He was given multiple cycles of R-CHOP chemotherapy (Cytoxan, Hydroxyrubicin, Oncovin, and Prednisone chemotherapy regimen), which led to tumor eradication. The patient, however, expired due to unknown reasons. The case highlights the major diagnostic modalities and treatment strategies for AITL and sheds light on the poor prognosis of the disease despite adequate management.
Publication Details
Page(s) 108-111
Published Journal: Pakistan Journal of Medicine and Dentistry, Volume: 10, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
Chemotherapy, Lymphoma, Angioimmunoblastic Lymphadenopathy, Non-Hodgkin, T-Cell
0

Citations

0

Downloads

63

Views